SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting More Done With Less Blood.

2.

3D virtual staining technology enables non-invasive observation of cancer tissue

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

We Don't Always Know What's 'Best' for Our Patients

5.

Study opens up possibility of bespoke prostate cancer treatment


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot